LSBio offers antibodies, proteins, and cDNAs specific to coronavirus proteins and host proteins involved in coronavirus disease progression. Reagents for investigating SARS-CoV-2, SARS-CoV, MERS, and HCoV coronavirus structural and non-structural proteins, as well as coronavirus-interacting host proteins such as ACE2, TMPRSS2, Cathepsin, and ADAM17 are available and approved for use in multiple applications. We have a wide selection of related recombinant proteins, native proteins, and over-expression lysates. Furthermore, we provide expression-ready ORF cDNA clones to coronavirus genes of prominent research interest.
LSBio offers over 150 antibodies to structural and non-structural coronavirus proteins, including antibodies for the detection of the spike (S), nucleocapsid (N), and envelope (E) proteins of both SARS-CoV and SARS-CoV-2. We also offer antibodies which detect human proteins known to interact with coronaviruses or to contribute to COVID-19 disease progression. Many of our antibodies are available in multiple conjugated forms and are designed for use in a range of assays including ELISA, IHC, Western Blot, IF, and Flow Cytometry.
View LSBio’s library of high-quality recombinant coronavirus proteins, produced in a variety of expression systems and ready for use in functional assays, high throughput screens, structural analysis studies, and a variety of other applications. Full length recombinant proteins to SARS-CoV-2 structural proteins are available for your COVID-19 research needs.
LSBio offers expression-ready ORF clones to a range of coronavirus genes intended for immediate transfection. SARS-CoV-2 clones are available for stable or transient mammalian and lentiviral expression.